News tagged with drug companies
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Medications
May 21, 2013 |
4.2 / 5 (5) |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
Farm bill: Senate rejects GMO labeling amendment
The Senate has overwhelmingly rejected an amendment allowing states to require labeling of genetically modified foods.
Health
May 23, 2013 |
not rated yet |
1
Breakup of physician, drug company relationship could improve health care, cut cost
A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, ...
Medications
May 20, 2013 |
5 / 5 (1) |
0
Bionic eye maker has vision of the future
Robert Greenberg got tired of hearing from senior engineers that it wasn't possible to build his product idea: a bionic eye that gives sight to the blind. "A lot of the folks straight out of school didn't know any better, ...
Medical research
May 06, 2013 |
5 / 5 (6) |
1
Renaissance in new drugs for rare diseases
Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, ...
Medications
May 13, 2013 |
not rated yet |
0
Drug manufacturer agrees to $500 million penalty (Update)
A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in fines and penalties for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown ...
Medications
May 13, 2013 |
not rated yet |
0
Higher prices for MS drug help drug firm Merck
(AP)—Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in first-quarter profit.
Other
May 14, 2013 |
not rated yet |
0
Faulty gene connected to ovarian cancer risk
In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expect ...
Cancer
Aug 09, 2011 |
not rated yet |
0
|
The cost of prescription drugs—a comparison of two countries
In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance continues to exceed comparable costs paid by the government in the United Kingdom (U.K.) ...
Medications
Nov 01, 2012 |
3.7 / 5 (3) |
1
US supreme court rejects challenge to new cigarette labeling
(HealthDay News) —The U.S. Supreme Court on Monday rejected a tobacco industry challenge to a controversial 2009 federal law that mandates graphic warning labels on cigarettes. The high court refused to ...
Health
Apr 22, 2013 |
5 / 5 (2) |
3
New study explores role of social responsibility in drug development
(Medical Xpress)—Though pharmaceutical companies that are developing "orphan drugs" do so mainly for the business potential, the companies also consider the effort as part of their corporate social responsibility, ...
Medications
Apr 01, 2013 |
not rated yet |
0
New drug extends survival in patients with drug-resistant prostate cancer
A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression ...
Cancer
Feb 01, 2012 |
5 / 5 (1) |
0
|
India's rejection of drug patent could reverberate
The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers. ...
Medications
Apr 01, 2013 |
not rated yet |
0
Supreme Court ruling supports generic drug makers
The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.
Medications
Apr 18, 2012 |
5 / 5 (1) |
0
